AFM
RMTI icon

Aspetuck Financial Management’s Rockwell Medical RMTI Stock Holding History

Aspetuck Financial Management’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-364
Closed -$7.42K – 159
2024
Q4 		$7.42K Buy
+364
New +$10.6K 0.01% 176

Other funds holding RMTI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Aspetuck Financial Management's RMTI Position: Q1 2025 in Review

Aspetuck Financial Management sold out of Rockwell Medical (RMTI) in Q1 2025, closing a stake of 364 shares — an estimated $7.42K sold.

Aspetuck Financial Management first reported a position in RMTI in Q4 2024 and held it in 1 quarter. The position peaked at $7.42K in Q4 2024. 46 funds tracked by Wall St. Rank hold RMTI as of Q1 2025.

  • Aspetuck Financial Management reported no remaining Rockwell Medical position as of Q1 2025 after selling out during the quarter.
  • Aspetuck Financial Management sold 364 Rockwell Medical shares in Q1 2025, an estimated $7.42K.
  • Aspetuck Financial Management first reported a position in Rockwell Medical in Q4 2024 and held it in 1 quarter.
  • Aspetuck Financial Management's Rockwell Medical position peaked at $7.42K in Q4 2024.
  • 46 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2025.

Based on Aspetuck Financial Management's 13F filing for Q1 2025, filed 23 Apr 2025.